October
Ph.D. must have been completed within the last 10 years
Three postdoctoral fellow programs that support outstanding scientists offer a unique opportunity for selected scholars to engage in a three-year fellowship of interdisciplinary research at the Beckman Institute. The fellowship appointment provides an annual stipend of $54,000, plus benefits and a research budget.
This grant is intended to support advanced post-doctoral fellows, instructors and assistant professors (or equivalent). Pre-doctoral students, first year post-doctoral fellows, faculty who serve(d) as a P.I. on a NIH R01 grant are not eligible.
These grants are intended to facilitate innovative research opportunities and supports basic, as well as translational and/or clinical investigators. All research must be relevant to understanding, treatment and prevention of serious psychiatric
disorders such as: schizophrenia; bipolar; mood and anxiety disorders; or early onset brain and behavior disorders. The BBRF Young Investigator program offers up to $35,000 a year for up to 2 years to enable promising investigators to either extend their research fellowship training or to begin careers as independent research faculty.
Offers scientists and engineers from a wide variety of disciplines unique opportunities to conduct research in a wide range of topics relevant to the Intelligence Community. The research is conducted by the postdocs, while working in partnership with a research advisor and collaborating with an advisor from the Intelligence Community. This is a unique opportunity which allows the postdoc to continue their research at any university or government lab of their choice.
Individuals are not eligible if they have more than 4 years of related postdoctoral research at the time of initial or resubmission application. There is no citizenship requirement for K99 applicants.
Citizenship requirements vary
Varies by program
Programs provide either direct (i.e., from NSF) or indirect (i.e., from an awardee institution) funding for students at the postdoctoral level or identify programs that focus on educational developments such as curricula development, training or retention.
Harvard Internal Opportunities | ||
April | The American School of Prehistoric Research (ASPR), which supports archaeological research and education in Old World prehistory, is offering financial support for Harvard graduate students and postdoctoral affiliates conducting summer field research in 2024. Eligible candidates must be attending a field program in Old World prehistory, and preference will be given to those who are at an early stage in their scholarly career, as well as those with financial need. Contact ASPR staff assistant Clara Alexander ( ) or the department executive officers: Rowan Flad ( ) or Dan Lieberman ( ). | |
February, March | The Arboretum offers fellowships and awards to students, post-doctoral researchers, and professionals of the biological and horticultural sciences. | |
January | The Center's programs and projects offer a variety of both pre-doctoral and post-doctoral research fellowships in diverse research areas. | |
November | The Developmental Award provides salary and research support for promising early-career investigators who are transitioning to independent funding. Applicants may be at the post-doctoral fellow, research fellow, instructor, research associate, research scientist, or assistant professor level at any Harvard University School or one of its affiliated institutions. Applications will be considered from candidates beginning at the time of their transition from a training grant or similar support to mentored independent research (K level) funding to the point at which they have received NIH R01 or similar level funding. | |
Varies by program | The Center for Astrophysics combines the resources and research facilities of the Harvard College Observatory and the Smithsonian Astrophysical Observatory under a single director to pursue studies of those basic physical processes that determine the nature and evolution of the universe. | |
October | The CHS supports postdoctoral scholars working on the ancient Greek world through the following programs: CHS Fellowships in Hellenic Studies; CHS/DAI Joint Fellowships; and Grants for Visiting Scholars. | |
November | The Center awards two fellowships to scholars with research interests in Global American Studies: the history of the United States in the world, and the world in the United States. Applications are welcomed from scholars with a variety of disciplinary backgrounds who bring a historical perspective to topics such as empire, migration, race, indigeneity, and ethnicity, and whose work investigates and/or interprets the history and experience in the United States of native peoples, or peoples of African, Asian, or Hispanic descent. | |
January | The Center awards postdoctoral fellowships for scholars who receive their PhD no later than September of the application year and no earlier than 5 years prior to the application deadline. | |
January | An Wang Postdoctoral Fellowships support scholars engaging in research relevant to the Center's mission: to advance scholarship in all fields of Chinese studies at Harvard. Applications are invited from scholars in any academic discipline, working on contemporary China or any period of Chinese history, who are no more than five years beyond the receipt of their Ph.D. | |
February | The Film Study Center (FSC) offers fellowships to both internationally eminent and emerging filmmakers, video artists, sound artists, and photographers whose creative projects seek to interpret the world, especially the fabric of human existence and cultural difference, through moving and still images and sounds. | |
February, May, August, November | The Foundations of Human Behavior Initiative (FHB) aims to drive transformative insights about the psychological, social, economic, political, and biological mechanisms that influence human behavior – and then translate that knowledge into cost-effective, scalable interventions that improve human well-being around the world. Applications from post-docs must be sponsored by a member of the Harvard ladder faculty and accompanied by a detailed letter from the faculty member evaluating the project and explaining the scientific merits of the project. | |
October | Under the guidance of a senior Harvard Chan School faculty member with compatible interests, Yerby Fellows develop research agendas, receive grant support, and actively pursue publication in peer-reviewed journals. The program creates a bridge between academic training in public health-related fields and entry-level faculty positions at institutions throughout the U.S. Applicants must have earned a doctorate in a public health-related discipline. | |
December | Supports researchers whose interests are in data science, broadly construed, including researchers with both a methodological and applications focus. The normal duration of the Fellowship is two years. Fellows will receive a generous salary as well as an annual allocation for research and travel expenses. | |
Rolling | The Dean’s Postdoctoral Fellowship (DPF) is a two-year research fellowship that provides funding in the amount of $50,000/year. Fellows receive additional opportunities for career enhancement, mentorship, seminars, workshops, and conferences, along with a robust support network, through the program. Applicant must be a U.S. citizen or permanent resident from a group that is historically underrepresented in the basic and social sciences, and have no more than two years of postdoctoral experience. | |
December | The Inequality in America Initiative seeks applications from recent doctoral degree recipients interested in working to address the multiple challenges of inequality. This program intends to seed new research directions; facilitate collaboration and mentorship across disciplines; develop new leaders in the study of inequality who can publish at the highest level, reach the widest audience, and impact policy; and deepen teaching expertise on the subject of inequality. | |
November | The Center welcomes applications from recent Ph.D. recipients from all fields within the humanities and the allied social sciences, typically centered around an annual theme. | |
| November | Fellowships enable outstanding young scientists to carry out research projects under the joint supervision of PIs from MPQ and Harvard. Fellows will be offered the opportunity to travel between both institutions on a regular basis, while profiting from the excellent colloquia series and scientific retreats taking place in the framework of the cooperation. To be eligible, applicants must have completed their PhD before starting the fellowship. |
February | This two-year award is intended to fund a postdoctoral fellow (in accordance with NIH stipend guidelines) who wants to examine MBB-related issues through interdisciplinary research and experiences. Applicant must have a Ph.D., M.D. or M.D./Ph.D. in an MBB-related field and no more than 1 year of postdoctoral experience. Research project must bridge at least two classical fields of study. | |
March, October | The Museum of Comparative Zoology (MCZ) at Harvard University periodically awards travel grants that support collection of specimens and data relating to the study of comparative zoology, which are known as Putnam Expedition Grants. | |
January | This yearlong program provides current Harvard graduate students and postdoctoral researchers an opportunity to participate in the crucial early stages of technology development by analyzing technologies’ commercialization potential and crafting marketing strategies. | |
| This program is currently on pause. | These awards of up to $750 are designed to support the professional development needs of postdocs by providing reimbursement for activities that directly enhance the individual’s professional growth, and which their PIs or faculty advisors may be unable to fund. Such activities include, but are not limited to, conference travel, workshop attendance, and course enrollment. The awards are open to full-time postdocs in all disciplines from any Cambridge-based school of Harvard University. |
February | The purpose of the fellowship is to enable the fellow to complete a major piece of writing in the field of legal history, broadly defined. Eligible applicants include those who have a first law degree, who have completed the required coursework for a doctorate, or who have recently been awarded a doctoral degree. A J.D. is preferred, but not required. Applicants who are beginning a teaching career in either law or history will also be considered. | |
January | To fulfill its aim of promoting research on Japan, the Reischauer Institute provides fellowships and grants for undergraduate and graduate students and postdoctoral scholars. Postdoctoral fellowships provide scholars with exceptional promise and opportunity to transform dissertations into publishable manuscripts. | |
January | The HURI brings scholars from the international academic community to Harvard for focused research on projects in Ukrainian history, literature, philology, culture, and other related areas of study in the humanities and social sciences fields. | |
January | The Institute annually appoints scholars who conduct individual research for a period of one to two semesters in a wide variety of fields related to African and African American Studies. Fellows work in a range of fields and interests, including art and art history, Afro-Latin American research, design and the history of design, education, hiphop, African studies, the African diaspora, African American studies, literature, and creative writing. | |
Varies by program | The Center welcomes applications from graduate students and postdoctoral scholars in various disciplines whose research involves important international, transnational, global, and comparative national issues that may address contemporary or historical topics, including rigorous policy analysis, as well as the study of specific countries and regions outside the United States. | |
January | The Program offers postdoctoral fellowships for social scientists in a broad range of fields, including anthropology, economics, education, history, law, political science, public health, public policy, and sociology. Projects that focus on Japan or Japan's international role from a comparative, historical, or global perspective are welcome. A knowledge of the Japanese language is not required. |
As one of the world’s leading academic institutions, Harvard University is committed to supporting top-quality Postdoctoral Fellows who will contribute to the University's mission of excellence in teaching and research, and who are interested in advancing new ideas and promoting enduring knowledge. Harvard offers access to intellectual and cultural resources that are as unique as they are unrivaled.
The Center for African Studies Postdoctoral Research Fellowship Program is aimed at providing opportunities for postdoctoral candidates to conduct independent research, publish, and increase knowledge in their fields of study that will be beneficial to the African continent and to prepare them to be successful in their chosen career paths. An applicant should have received their PhD (preference will be given to those who completed PhD in the last five years) and hold an academic appointment at a university or research institution in Africa. This includes those with a commitment of appointment at the time of application. The fellowship will support the development of a research project at selected Harvard University schools, departments, or laboratories in the field of their choice.
The program offers 18-month postdoctoral fellowships with 12 months spent at the scholars’ home institution and six months spent in stipend-supported residency at Harvard University.
APPLICATIONS FOR THE 2024-2026 COHORT WILL OPEN FRIDAY, MARCH 1, 2024. APPLICATION DEADLINE: APRIL 30, 2024.
The program is established for Africa-based researchers who intend to continue/return to work in African academia. Fellows will be selected based on academic talent in their fields and will have an opportunity to work on their pedagogical and research skills to further their professional development. Fellows will have completed their respective doctoral programs at institutions from anywhere around the world (preference will be given to those who completed the PhD in the last five years). PhD holders who currently hold a paid academic appointment, which will be active through the duration of the fellowship period, with any of the following institutions are eligible to apply.
Under the terms of appointment, fellows will be required to assume the following responsibilities:
A faculty review committee under direction of the CAS Oppenheimer Faculty Director will use the following criteria to identify final award recipients:
Interested candidates who meet the eligibility criteria will need to submit an online proposal through the Harvard University Funding Portal by April 30, 2024, at 11:59pm ET . The application submission site will open March 1.
Complete the online application in the Harvard University Funding Portal and upload required documents as prompted. Application link: https://bit.ly/4bXOO0c
The Harvard CAS Postdoctoral Research Fellowship application is hosted by Qualtrics and resides in a secure, encrypted environment that requires applicants to register to access the application. The registration is a one-time event with the application link sent to your inbox. Be advised that your application should be done on your regularly used computer to be able to save and return to your application. We strongly recommend that you use current generation browsers whenever possible. Google Chrome, Firefox, and Safari are the preferred browsers for this application. You may preview the application here .
Please Note: A complete application consists of fields submitted through the Harvard University Funding Portal and all requested attachments uploaded as PDFs into the application system. In addition, a confidential letter of recommendation is requested from the postdoc’s supervisor at their home institution who is familiar with your academic work as well as by a faculty mentor at Harvard University. Note that it is the responsibility of the applicant to ensure that the confidential letters are submitted by the deadline due date.
The detailed components of the complete application are shown in the application form. An application will not be considered complete without these confidential letters from the mentors.
What is the application deadline? Applications are due on April 30, 2024. Complete applications, including letters of recommendation, must be received by the application deadline.
How can I identify a Harvard faculty mentor? We recommend that candidates start with our list of CAS Faculty Affiliates to identify a potential research mentor. Prospective fellows may reach out to faculty by e-mail to inquire about their availability to serve as a faculty mentor. We advise including a copy of your research proposal and CV with your request as well as a summary of how you see your research project aligning with the work of the Harvard faculty mentor. Candidates may also visit websites for specific Harvard University departments or schools to find faculty members in their research field. Unfortunately, due to a high volume of inquiries, we are unable to provide individualized assistance in identifying a Harvard faculty mentor.
Is my university or institution eligible? All universities in Africa are eligible to participate in the fellowship program beginning this year. If you are unsure as to whether you research institution qualifies, please contact Rosaline Salifu at: [email protected]
How are applicants selected? How many fellowships will be awarded? After the application deadline, all applications are given administrative review to verify the applications are complete. Incomplete applications will not move forward for review. Applications are then shared with a faculty review committee comprised of members of the CAS Faculty Executive Committee, who will shortlist up to five candidates. Faculty will make their selections based on the academic merits and feasibility of the candidate’s research proposal, the candidate’s perceived ability to excel in academic career, and the strength of the faculty mentors’ recommendations. Shortlisted candidates will be offered a one-hour interview with the CAS Oppenheimer Faculty Director, Executive Director, and at least one member of the faculty review committee. Up to three fellowships will be awarded each year.
What is the timeline for the fellowship? When should the residency begin? Fellowships should begin on September 1 in the year of the application deadline (applications submitted in 2022 should propose a start date of September 1, 2022). The residency may occur within any consecutive six-month period following the September 1 start date and should be agreed upon by your faculty mentors at Harvard and at your home institution. Note for planning purposes that the Fall term at Harvard takes place from early September through early December and the Spring term from late January through early May.
Are fellowship funds paid by Harvard University directly or through the home institutions of the fellows? Harvard University will pay fellows a stipend during their residency. From this stipend, fellows are expected to pay for housing, health insurance, food, transportation, books and supplies and other expenses. Payments will be made in fellows name ONLY for the six months in residence in Cambridge.
Are Research Funds paid directly to the Fellow or to the University?
Research funds are managed by the home institutions of fellows. Upon receipt of the fellowship, a Research Agreement that governs the scope of work, expenditure and a payment plan, as well as fund disbursements will be sent to the fellow’s institution for approval. Fellows can then draw on the funds for the sole purposes of their research work and purchases during their fellowship. Funds cannot be reassigned, and only costs directly related to the fellow’s research expenses will be reimbursed.
Do I need to receive ethical clearance from my institution or Harvard University to begin my field work?
You will need both. Ethical clearance should be sought for all your research work in which human or animal subjects are involved prior to commencement of your study in the field. You will need to be familiar with the Institutional Review Board (IRB) requirements and approval processes as it relates to your work from your school as well as Harvard University.
Accelerate your career by pursuing groundbreaking research with world-class scientists.
Our Postdoctoral Research Fellow Program aims to be a best-in-industry experience for PhD graduates, providing academic focus in a large pharmaceutical environment. With Merck’s resources, reach and expertise at their fingertips, our postdoctoral fellows work under the mentorship of our dedicated researchers and alongside a diverse team of scientists striving to transform world-class science into life-changing medicines and vaccines.
Obtain unmatched hands-on experience in drug discovery and development
Generate scientific results and publish in high-impact journals
Build a strong foundation in the scientific community through meaningful connections with experts and peers
Gain unparalleled experience to pursue preferred career opportunities in research and development
By collaborating closely with our scientists to apply the latest cutting-edge research technologies, our postdoctoral fellows are primed to excel in an institution dedicated to breakthrough innovation in research and development.
Postdocs working across our R&D laboratories
Alumni, to date
Publications since 2015
Our scientists and postdocs are encouraged to be active members of the scientific community and have published papers in numerous peer-reviewed, thought-leading publications. Explore our publications
Every day our scientists, from all backgrounds and disciplines, work together to use the power of leading-edge science to save and improve lives.
Explore how your ideas can grow with mentorship from leading scientific experts through our established postdoctoral research fellow program.
How we’re advancing the best internal and external science to progress our pipeline for patients
We follow the science where we can make the greatest difference
Our scientists are accelerating research by looking to improve anti-tumor immune response, targeting specific cancer cells and helping inhibit cancer growth
Merck scientists explain how new technologies can accelerate the drug discovery process as we use the power of leading-edge science to save and improve lives
Merck scientists say the “Goldilocks” chemical modality could lead to new ways to impact disease
Listen as specialists from Merck discuss what they’re most excited about in researching potential treatments for neurologic disorders
Where our science happens
Our research and development starts with the capabilities and expertise at our facilities, but we're open to collaboration anywhere the science leads us.
Meet our scientists
Meet our research leaders who are dedicated to pushing scientific boundaries.
How we invent
Our teams of scientists bring together diverse expertise and background, combined with cutting-edge technologies, to help discover the next scientific breakthrough for patients.
This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2023 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov). No Duty to Update The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.
Welcome to merck.com.
By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.
INFORMATION FOR
Postdoctoral associates and fellows are an essential part of scientific advancement and research. The Yale School of Public Health has an abundance of postdoctoral positions at any given time in multiple disciplines.
Following are some of our ongoing opportunities for early career researchers.
YSPH has several ongoing postdoctoral fellowship programs focused on training the next generation of researchers. For other grant-funded postdoctoral positions, please visit our Careers page.
(move-kaz) molecular virology/epidemiology training in kazakhstan, research education institute for diverse scholars (reids), transdisciplinary research on energetics and cancer training workshop.
An annual, in person 5-day transdisciplinary training course in energy balance and cancer research for early career investigators (i.e., junior faculty and postdocs).
An official website of the United States government
Here's how you know
Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS. A lock ( Lock Locked padlock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
View guidelines, important information about nsf’s implementation of the revised 2 cfr.
NSF Financial Assistance awards (grants and cooperative agreements) made on or after October 1, 2024, will be subject to the applicable set of award conditions, dated October 1, 2024, available on the NSF website . These terms and conditions are consistent with the revised guidance specified in the OMB Guidance for Federal Financial Assistance published in the Federal Register on April 22, 2024.
All proposals must be submitted in accordance with the requirements specified in this funding opportunity and in the NSF Proposal & Award Policies & Procedures Guide (PAPPG) that is in effect for the relevant due date to which the proposal is being submitted. It is the responsibility of the proposer to ensure that the proposal meets these requirements. Submitting a proposal prior to a specified deadline does not negate this requirement.
Supports postdoctoral research in the social, behavioral and economic sciences and/or activities that broaden the participation of underrepresented groups in these fields.
The Directorate for Social, Behavioral and Economic Sciences (SBE) offers Postdoctoral Research Fellowships to encourage independence early in the fellow's career by supporting his or her research and training goals. The research and training plan of each fellowship must address important scientific questions within the scope of the SBE directorate and the specific guidelines in this solicitation. The SPRF program offers two tracks: (I) Fundamental Research in the SBE Sciences (SPRF-FR) and (II) Broadening Participation in the SBE Sciences (SPRF-BP). See the full text of the solicitation for a detailed description of these tracks.
(703) 292-7376 | SBE/OAD | ||
Program Analyst | (703) 292-2184 | SBE/OAD |
Organization(s).
Marie Skłodowska-Curie Actions
Developing talents, advancing research
Objective of postdoctoral fellowships.
The objective of PFs is to support researchers’ careers and foster excellence in research. The Postdoctoral Fellowships action targets researchers holding a PhD who wish to carry out their research activities abroad, acquire new skills and develop their careers. PFs help researchers gain experience in other countries, disciplines and non-academic sectors.
There are 2 types of Postdoctoral Fellowships:
Both types of fellowships may also include short-term secondments anywhere in the world during the fellowship (except during the return phase of a Global Fellowship).
In an effort to build bridges between the academic and non-academic sector, researchers can receive additional support to carry out a placement of up to 6 months in a non-academic organisation based in an EU Member State or Horizon Europe Associated Country. This placement needs to take place at the end of their fellowship.
For Postdoctoral Fellowships in research areas covered by the Euratom Research and Training Programme , researchers need to be nationals or long-term residents of an EU Member State or a Euratom Associated Country. The beneficiary organisation recruiting the researcher also needs to be established in an EU Member State or Euratom Associated Country.
Interested researchers submit an application together with a host organisation, which can be a university, research institution, business, SME or other organisation based in an EU Member State or Horizon Europe Associated Country. All disciplines are eligible for Postdoctoral Fellowships, including research areas covered by the Euratom Research and Training Programme.
Researchers interested in PFs
As from 2022, resubmission restrictions will apply for applications that received a score below 70% the previous year.
Seals of Excellence will be awarded to applications with a total score equal to or higher than 85% , but which cannot be funded due to lack of budget available under the call.
The beneficiary receiving EU funding needs to recruit the researcher for the total period of the fellowship.
The EU provides support for the recruited researcher in the form of
In addition, funding is provided for
Researchers: prepare an application with a host organisation of your choice.
If you are an experienced researcher interested in developing your own research project you can apply for Postdoctoral Fellowships.
You will need to
To find a host organisation
Offers are often in very concrete fields of research proposed by the host organisation. In many cases, you will be in contact with a supervisor to develop your application. You will need to check carefully the requirements to make sure you are eligible to apply.
All relevant documents are available for each call on the Funding and Tender Opportunities Portal, including
For more information on the application and evaluation process and contact points for further guidance
As an organisation based in an EU Member State or Horizon Europe Associated Country you can develop an application jointly with an experienced researcher for MSCA Postdoctoral Fellowships funding.
To attract the most talented researchers you can post hosting offers on Euraxess and other major job portals, gaining access to a pool of international minds and high potentials interested in applying with your organisation.
As the host organisation you will be responsible for submitting the application to MSCA Postdoctoral Fellowships on behalf of the researcher.
The completed proposal, including all annexes
If the submitted proposal is retained for funding, your organisation will be in charge of
Applicants can
All relevant documents are available on the dedicated call page on the Funding and Tender Opportunities Portal, including
Thanks for your feedback.
We are happy to see that your experience was positive. Don't forget to share the pages you like with your friends and colleagues.
If you need to ask a question, please contact Europe direct .
This website uses cookies, including third party ones, to allow for analysis of how people use our website in order to improve your experience and our services. By continuing to use our website, you agree to the use of such cookies.
AAUW’s International Postdoctoral Research Fellowship Program promotes education and equity for women by investing in international applicants who will be pursuing postdoctoral research in the U.S., with the intention of applying their expertise, professional skills and leadership in the context of their home countries. In addition, up to 6 awards are available to Graduate Women International ( see the list of GWI affiliates ) members for study in any country other than their own. The program is specifically designed for women who are non-U.S. citizens or permanent residents, with a track record of academic excellence and empowering other women and girls. AAUW’s International Fellowships have been supporting international women pursuing full-time postgraduate and postdoctoral research in the United States since 1917.
International Postdoctoral Research Fellowships carry a stipend of $50,000. Stipends are payable to fellows only and are disbursed in two equal payments at the beginning and the midpoint of the fellowship term.
International Postdoctoral Research Fellowships are available for the following broad discipline areas:
Fellowship recipients must be non-U.S. citizens or permanent residents.
The following are not eligible for consideration:
How to apply.
International Scholarship & Tuition Services (ISTS) serves as the application portal for AAUW International Fellowships. Please follow the steps below to start the application process:
If you experience technical difficulties, please contact [email protected] or (866) 795-4892.
In addition to a narrative application, all applicants are required to submit the following:
Note: AAUW does not accept references from dossier services, such as Parment or Interfolio, and standardized or form-letter recommendations are discouraged.
A certified English translation is required for all materials provided in a foreign language. Translations must bear a mark of certification or official signature that the translation is true and complete.
If the name differs from the one stated in the application, an explanation must be provided, such as a marriage certificate or a court letter of name change.
Applicants are responsible for the submission of all required documents. Incomplete applications will be considered at the discretion of AAUW.
Fellowships are awarded on a competitive basis according to funds available in a given fiscal year.
Applications to the International Fellowships are reviewed by panels of distinguished scholars and experts in the Natural & Physical Sciences fields.
Review panels meet once a year to review applications for funding. Panel funding recommendations are subject to final approval by AAUW.
Prior to the International Fellowships Panel Review, AAUW’s Fellowships & Grants Team reviews applications for completeness and ensures compliance with eligibility requirements.
Each application is subsequently read by two panel reviewers. Reviewers assess applications based on the selection criteria described above.
In most instances, the fellowship stipend is subject to a tax rate of either 14 or 30 percent, depending on relevant tax statuses and treaties. AAUW will withhold the necessary taxes from the stipends.
AAUW provides general tax guidelines to facilitate awardee compliance with United States tax law. However, AAUW strongly recommends that recipients consult a tax professional. AAUW does not provide any tax advice. Personal tax situations differ, and recipients are responsible for determining their AAUW award’s taxability in accordance with the U.S. Internal Revenue Service, state laws, or in any country where they reside. Additional resources include the U.S. IRS (including the U.S. IRS Classification of Taxpayers for U.S. Tax Purposes ) and Social Security Administration , as well as campus admissions, financial aid, and international student offices.
Disclaimer: These guidelines are provided for informational purposes only and should not be considered financial or legal advice. AAUW encourages students to seek advice from a qualified tax or financial advisor if needed.
The U.S. tax year runs from January 1 to December 31, with an annual tax filing deadline of April 15.
AAUW awardees can have one of the following tax statuses:
1. Foreign persons conducting their AAUW fellowship year in the U.S., residing inside or outside the U.S.
2. Foreign persons residing and conducting their AAUW project/fellowship outside the U.S.
3. U.S. Persons (U.S. Citizens, U.S. Permanent Residents, and U.S. Resident Aliens)
Awardees must:
1. Foreign persons conducting their AAUW fellowship year in the U.S., residing inside or outside the U.S : Foreign persons, including nonresident aliens, who are conducting their AAUW project in the U.S. during the award year must submit a Form W‐8BEN . This includes recipients who are conducting their AAUW project at a U.S. institution (e.g., pursuing research or a degree at a U.S.‐based institution), even if they are residing outside the U.S.
2. Foreign persons residing and conducting their AAUW project/fellowship outside the U.S.: Foreign persons, including nonresident aliens, who reside outside the U.S. and who are performing their AAUW project plan outside the U.S. do not need to submit a tax form.
3. U.S. Persons (U.S. Citizens, U.S. Permanent Residents, and U.S. Resident Aliens): U.S. persons, including U.S. resident aliens, must submit a Form W9 . The form must include a U.S. Individual Taxpayer Identification Number or U.S. Social Security Number .
1. Foreign persons conducting their AAUW fellowship year in the U.S., residing inside or outside the U.S : The U.S. IRS requires tax filers to provide a U.S. Individual Taxpayer Identification Number or U.S. Social Security Number to file taxes. Certain recipients requesting tax exemptions must submit a tax number in their W‐8BEN. Others do not. However, as the process to obtain one of these numbers can be lengthy, AAUW strongly recommends that recipients apply for the appropriate number as soon as possible and submit it within their Form W‐8BEN.
2. Foreign persons residing and conducting their AAUW project/fellowship outside the U.S.: Foreign persons, including nonresident aliens, who reside outside the U.S. and who are performing their AAUW project plan outside the U.S. do not need to submit U.S. taxpayer identification number.
3. U.S. Persons (U.S. Citizens, U.S. Permanent Residents, and U.S. Resident Aliens): U.S. persons, including U.S. resident aliens must provide a U.S. Individual Taxpayer Identification Number or U.S. Social Security Number .
1. Foreign persons conducting their AAUW fellowship year in the U.S., residing inside or outside the U.S: Under U.S. law, fellowship awards to foreign persons conducting their fellowship year in the U.S. are taxable. AAUW is required by law to withhold the following amount to meet these tax obligations:
2. Foreign persons residing and conducting their AAUW project/fellowship outside the U.S.: AAUW does not withhold any amount for payment of taxes.
3. U.S. Persons (U.S. Citizens, U.S. Permanent Residents, and U.S. Resident Aliens): The determination of whether there is a tax obligation associated with the receipt of an AAUW fellowship is the sole responsibility of the applicant. Specific questions regarding income tax matters should be addressed with the U.S. Internal Revenue Service, the applicant’s financial aid office or a personal tax adviser.
Certain countries have tax treaties with the U.S. that may exempt part or all the AAUW award from taxation or specify a unique US tax rate for citizens of that country. Please review the U.S. IRS’s U.S. Income Tax Treaties—A to Z and consult your embassy to determine if your country has a tax treaty with the US and if so, use the tax withholding rate that applies to you to appropriately record this information in your form W‐8BEN . Please note you must complete Part II of this form and submit it to AAUW. If you do not have a U.S. taxpayer identification number and are requesting an exemption, you may enter a foreign tax identifying number .
1. Foreign persons conducting their AAUW fellowship year in the U.S., residing inside or outside the U.S must follow the U.S. IRS reporting guidelines for each tax year they received funding. By March 15 of each year, AAUW will provide a 1042‐S Form to each recipient. This form indicates the amount of the stipend paid during the previous calendar year and any taxes withheld.
2. Foreign persons residing and conducting their AAUW project/fellowship outside the U.S.: AAUW does not report stipend information to the U.S. IRS and does not provide tax‐related forms.
3. U.S. Persons (U.S. Citizens, U.S. Permanent Residents, and U.S. Resident Aliens): AAUW does not report stipend information to the U.S. IRS and does not provide tax‐related forms.
Applicants recommended for an award, but whose discipline or institution of study is different than envisioned at the time of application will be disqualified.
International Fellowships may be used for tuition, fees and course-required expenses like books and supplies, as well as housing, food, and other living expenses (including childcare).
Awarded fellowship funds may not be expended on costs incurred prior to the fellowship term start date or after the fellowship term end date.
International Postdoctoral Research Fellows are prohibited from pursuing a degree during their fellowship year.
International Postdoctoral Research Fellows are required to devote 100% of their working time and intellectual effort to their research.
Is it possible to be notified of my award status prior to April 15th?
No, AAUW is not able to honor requests for earlier notification.
If I had to decline an AAUW award in the past due to eligibility concerns or personal reasons, am I allowed to reapply?
Yes, if you were awarded an AAUW fellowship or grant but had to decline it without receiving your stipend, you are eligible to reapply.
You must enable JavaScript to sign up.
NOTICE – The Fonds de recherche du Québec (FRQ) was established on June 1, 2024, in accordance with the Act to amend the Act respecting the Ministère de l’Économie et de l’Innovation with respect to research. The Fonds de recherche du Québec – Nature et technologies (FRQNT), the Fonds de recherche du Québec – Santé (FRQS) and the Fonds de recherche du Québec – Société et culture (FRQSC) have since been regrouped into the new FRQ, which continues their existence. The rights and obligations of the FRQNT, FRQS and FRQSC have become those of the FRQ; activities continue as usual.
Please note that if you come across an old name or logo of one of the Fonds de recherche du Québec in the program rules or on the website, it should now read as follows:
Thank you for your understanding.
Competition year : 2025-2026
Deadline (application) : October 17 th , 2024 at 16:00 (EST)
Announcement of results : End of April 2025
Amount : 45 000$/year + supplement for production costs
Duration : 6 to 24 months + possibility of additional 12 months
Accessibility options.
Adjust the text size as you need by clicking on the buttons below
Adjust the visual style of the site by selecting the one that suits you best from the choices available below:
Go to our accessibility section to learn more about our policies and the accessibility of our website.
National Institutes of Health ( NIH )
National Institute on Aging ( NIA )
National Institute on Alcohol Abuse and Alcoholism ( NIAAA )
National Institute of Arthritis and Musculoskeletal and Skin Diseases ( NIAMS )
Eunice Kennedy Shriver National Institute of Child Health and Human Development ( NICHD )
National Institute of Neurological Disorders and Stroke ( NINDS )
R15 Research Enhancement Award (REA)
See Part 2, Section III. 3. Additional Information on Eligibility.
The purpose of this HEAL Initiative program is to: (1) support basic and mechanistic pain research from R15-eligible undergraduate-focused serving institutions, health professional schools or graduate schools; (2) promote integrated, interdisciplinary research partnerships between Principal Investigators (PIs) from R15-eligible institutions and investigators from U.S. domestic institutions; and (3) enhance the pain research environment at the R15-eligible institution for health professional students, undergraduate and/or graduate students through active engagement in pain research.
Applications in response to this notice of funding opportunity (NOFO) should include plans to accomplish these goals. Specifically, applications should include a rigorous plan for conducting basic and mechanistic pain research in the Research Strategy section of the application . In addition, a research partnership between the PIs institution and at least one investigator from a separate U.S. domestic institution that provides resources and/or expertise that will enhance the proposed pain research program must be included in a separate Team Management Plan. The proposed partnership will be a sub-award agreement(s) with at least one partnering institution, which does not need to be R15-eligible. The budget of all sub-awards must not exceed one third of the total budget. Furthermore, applications must include a Facilities & Other Resources document that demonstrates active involvement of health professional students, undergraduate and/or graduate students from the R15-eligible institution(s) in the proposed pain research projects.
This Notice of Funding Opportunity (NOFO) requires a Plan for Enhancing Diverse Perspectives (PEDP).
30 days before application due date.
Application Due Dates | Review and Award Cycles | ||||
---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
November 19, 2024 | Not Applicable | December 18, 2024 | March 2025 | May 2025 | July 2025 |
October 28, 2025 | October 28, 2025 | November 24, 2025 | March 2026 | May 2026 | July 2026 |
October 27, 2026 | October 27, 2026 | November 23, 2026 | March 2027 | May 2027 | July 2027 |
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
No late applications will be accepted for this Notice of Funding Opportunity (NOFO).
Not Applicable
It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide , except where instructed to do otherwise (in this NOFO or in a Notice from NIH Guide for Grants and Contracts ).
Conformance to all requirements (both in the How to Apply - Application Guide and the NOFO) is required and strictly enforced. Applicants must read and follow all application instructions in the How to Apply - Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the How to Apply - Application Guide , follow the program-specific instructions.
Applications that do not comply with these instructions may be delayed or not accepted for review.
There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.
Section i. notice of funding opportunity description.
Applications in response to this notice of funding opportunity (NOFO) should include plans to accomplish these goals. Specifically, applications should include a rigorous plan for conducting basic and mechanistic pain research projects in the Research Strategy section of the application. In addition, a research partnership between the PIs institution and at least one investigator from a separate U.S. domestic institution that provides resources and/or expertise that will enhance the proposed pain research program must be included in a separate Team Management Plan. The proposed partnership will be a sub-award agreement(s) with at least one partnering institution, which does not need to be R15-eligible. The budget of all sub-awards must not exceed one third of the total budget. Furthermore, applications must include a Facilities & Other Resources document that demonstrates active involvement of health professional students or undergraduate and/or graduate students from the R15-eligible institution(s) in the proposed pain research projects.
The National Institutes of Health (NIH) Helping to End Addiction Long-term ® Initiative, or NIH HEAL Initiative ® , bolsters research across NIH to (1) improve treatment for opioid misuse and addiction and (2) enhance pain management. More information about the NIH HEAL Initiative is available at https://heal.nih.gov/ . Research shows that diverse teams working together and capitalizing on innovative ideas and distinct perspectives outperform homogeneous teams. Scientists and trainees from diverse backgrounds and life experiences bring different perspectives, creativity, and individual enterprise to address complex scientific problems. See the Notice of NIHs Interest in Diversity ( NOT-OD-20-031 ) for more details. Promoting diversity in the pain research workforce is crucial to promoting future scientific advances in this area and to achieve the NIH HEAL Initiatives workforce development goals.The initiative has funded multiple pain workforce enhancement programs that support early-career investigators. Despite these efforts, the NIH HEAL Initiative can benefit from additionally supporting R-15 eligible institutions that involve undergraduate, graduate or health professional school/colleges students in pain research.
Since Fiscal Year (FY) 1985, NIH has made a special effort to stimulate research at educational institutions that provide baccalaureate and/or advanced degrees for a significant number of the nations research scientists who have not been major recipients of NIH support. NIH has implemented two parent award programs, the Academic Research Enhancement Award (AREA) program ( PAR-21-155 ) and Research Enhancement Award Program (REAP) ( PAR-22-060 ), to provide research experiences to health professional or undergraduate and/or graduate students pursuing biomedical or behavioral research at U.S. higher education institutions. Utilizing these two programs will further promote a diverse pain research workforce. This Pain Research Enhancement Program (PREP) will further support meritorious collaborative pain research from designated educational levels in the NIH HEAL Initiative, using the NIH Research Enhancement Award programs as a guide. Specifically, this NOFO aims to support new scientific solutions to the national opioid public health crisis byestablishing new research partnerships that will lead to research experiences for undergraduate, graduate, and health professional students, to further enhance the pool of potential participants in the pain research pipeline.
Program Objectives:
The purpose of this HEAL Initiative program is to: (1) support basic and mechanistic pain research from R15-eligible undergraduate-focused serving institutions, health professional schools or graduate schools; (2) promote integrated, interdisciplinary research partnerships between Principal Investigators (PIs) from R15-eligible institutions and investigators from U.S. domestic institutions; and (3) enhance the pain research environment at the R15-eligible institution for health professional students, undergraduate and/or graduate students through active engagement in pain research. Successful applications will include plans detailing how they intend to accomplish all three goals. Please refer to Section III for specific R15 eligibility information. Although preliminary data are not required for an R15 application, they may be included if available. The scientific foundation for the proposed research should be based on published research and/or any available preliminary data.
Objective 1: Develop Small-Scale Basic and Mechanistic Pain Research Projects
Proposed research projects should be hypothesis driven and use a rigorous scientific design to generate research data/evidence and advance scientific knowledge. Applications should include objectives that are attainable within the 3-year grant period.
Pain research projects may include, but are not limited to, the study of: nociception and/or pain processing in non-pain populations, acute pain, cancer pain, chemotherapy-induced neuropathy, chronic pain, diabetic neuropathy, eye pain, gynecologic pain, headache, musculoskeletal pain, myofascial pain, obstetric pain, osteoarthritis, pain conditions across the lifespan (including in the context of aging), pain co-occurring with substance use disorders (SUDs), painful disorders of the orofacial region, painful neuropathy, post-stroke pain, post-surgical pain, sickle cell pain, and/or visceral pain. Innovative pain research topics that propose an interdisciplinary mechanistic pain research are considered high program priority under this initiative.
Projects may focus on basic pain research with pre-clinical ( e.g., animal or in silico ) models or involve research participants ( e.g., observational studies, epidemiological studies, secondary data analyses, or device development). Alternatively, investigators may propose a mechanistic and/or Basic Experimental Studies involving Humans (BESH) clinical trial as described below. Clinical trials designed primarily to determine the safety, tolerability, and/or clinical efficacy of an intervention will be considered non-responsive to this NOFO and withdrawn without review .
For this NOFO, only the following types of clinical trials will be supported:
NIH defines a clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes ( https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-015.html ). For further clarification on how NIH defines the different types of clinical trials, please refer to the following resources:
Objective 2: Promote Integrated, Interdisciplinary Research Partnerships
A second key objective of this NOFO is to promote new research partnerships among investigators at R15-eligible institutions with separate (legally distinct) investigators at domestic research institutions. Investigators can have a multitude of research expertise that aligns with the proposed research projects and/or resources that can be shared to enhance the proposed research. Applications must propose a collaboration with at least one sub-award holder from a separate U.S. domestic research institution and should include details of how the collaboration will enhance the R15-research program must be described. Applications are permitted to have a subaward to a non-R15-eligible institution. However, it is expected that PD/PI(s) from R15-eligible institution(s) will lead the proposed project and complete most of the research at the R15-eligible institution. As such, PI(s) from R15-eligible institutions must serve as the contact program director (PD)/PI for the project. Additionally, no more than one third of the total budget for the project may be used by the identified sub-award institution.
Applications that propose new interdisciplinary are considered a high program priority under this NOFO. Interdisciplinary partnership could include, but are not limited to, any two or more areas of research expertise from the following:
In addition, a Team Management Plan is required as part of Objective 2. Studies of team science have highlighted the need for effective management structures to achieve program goals. Many resources exist to aid in developing effective team-based programs (e.g., the National Cancer Institute Collaboration and Team Science Field Guide ). The Team Management Plan focuses on management of the whole team/key personnel. Because teams will likely include individuals from widely divergent scientific backgrounds, teams must have a shared vision and a defined plan for communication and management of shared responsibilities, interpersonal interactions, and professional credit. The Team Management Plan should be included as an attachment (three pages maximum) to this application. It should address how the research team, including the PI from R15-eligible Instiution and collaborator(s), will work together to accomplish program objectives. See the application instructions for Other Attachments on the SF424(R&R) Other Project Information in Section IV.2 Instructions for Application Submission for details. The Team Management Plan should address the following points:
Objective 3: Enhance the Research Environment by Engaging Students
The third objective of this program is to enhance the pain research environment at the R15-eligible institution by engaging and providing research opportunities to health professional students or undergraduate and/or graduate students. A Facilities & Other Resources document is required to describe how the proposed research will enhance the pain research environment at the R15-eligible institution. Two-thirds of the proposed research project team should comprise personnel from the R15-eligible institutions, including health professional students, or graduate students or undergraduate students from the primary R15-eligible institution. Although the proposed research project must be led by the identified PD/PI, applications with strong and innovative student engagement are of high program priority. If participating students have not yet been identified, the number and academic stage of those to be involved should be provided. Applications should identify which aspects of the proposed research will include student participation. Student involvement may include participation in the design of experiments, collection and analysis of data, execution and troubleshooting of experiments, participation in research meetings, and discussion of future research directions. When applicable, it is highly desirable that student participation also include presentation of research at local and/or national meetings (including the HEAL Annual Scientific Meeting and "Positively Uniting Researchers of Pain to Opine, Synthesize, & Engage" {PURPOSE} meeting), publication of journal articles, and collaborative interactions. By engaging in these activities and collaborating on pain-focused research projects at early stages of training, students will be better prepared and motivated to pursue careers in pain research. Please see Section III for a list of eligible students.
This NOFO aims to support pain research grants, not training or fellowship program s. As such, applications should not include training plans such as didactic training or non-research activities related to professional development. Likewise, applications should not include independent student research projects. For applications that propose a clinical trial, the PD/PI must be the responsible individual of record for oversight of the trial though students can take part in all components of a clinical trial. Oversight includes (but is not limited to): interacting with relevant Institutional Review Board (IRB) staff; reviewing all informed consent documents; reporting potential serious adverse events; and maintaining responsibility for patient safety. However, the student can gain experience in all these components in conjunction with the individual leading the trial. Applications submitted to this NOFO may include additional investigators to those outlined above, including additional collaborators or consultants, or other individuals such as high school students, post-baccalaureate participants, postdoctoral fellows, or clinical fellows. However, involvement of such individuals does not fulfill the goal of enhancing the R15-eligible institutional environment and should account for less than one third of the overall proposed project team.
Additional Information
Non-responsiveness Criteria:
Applications deemed to be non-responsive will not proceed to review and will be withdrawn. Applications with one or more of the following characteristics are considered non-responsive to this NOFO:
Contacting Program Officers Prior to Submission
Applicants are strongly encouraged to consult with program staff as plans for an application are being developed.
Rigor and Reproducibility
NIH strives for rigor and transparency in all research it funds. For this reason, the NIH HEAL Initiative explicitly emphasizes the NIH application instructions related to rigor and transparency ( https://grants.nih.gov/policy/reproducibility/guidance.htm ) and provides additional guidance from individual NIH institutes and centers (ICs) to the scientific community. For example, the biological rationale for the proposed experiments must be based on rigorous and robust supporting data, which means that data should be collected via methods that minimize the risk of bias and be reported in a transparent manner. If previously published or preliminary studies do not meet these standards, applicants should address how the current study design addresses the deficiencies in rigor and transparency. Proposed experiments should likewise be designed in a manner that minimizes the risk of bias and ensures validity of experimental results.
Proposed research projects should incorporate adequate methodological rigor where applicable, including but not limited to a clear rationale for the chosen model(s) and primary/secondary endpoint(s), clear descriptions of tools and parameters, blinding, randomization, adequate sample size, prespecified inclusion/exclusion criteria, appropriate handling of missing data and outliers, appropriate controls, pre-planned analyses, and appropriate quantitative techniques.
Applications should also clearly indicate the exploratory vs. confirmatory components of the study, consider study limitations, and plan for transparent reporting of all methods, analyses, and results so that other investigators can evaluate the quality of the work and potentially perform replications. NIH intends to maximize the impact of NIH HEAL Initiative-supported projects through broad and rapid data sharing and immediate access to publications ( https://heal.nih.gov/about/public-access-data ). Guidelines for complying with the HEAL Public Access and Data Sharing Policy can be found at https://heal.nih.gov/data/complying-heal-data-sharing-policy . More details about NIH HEAL Initiative data sharing are described in Section IV.
Clinical Trial Accrual Policy:
For applications that are proposing to conduct a clinical trial, a series of clinical recruitment milestones detailing completion of the clinical trial and providing contingency plans to proactively confront potential delays or disturbances in attaining the clinical recruitment milestones must be included along with a study timeline in the PHS Human Subjects and Clinical Trials Information form. Continuation of the award is conditional upon satisfactory progress, availability of funds, and scientific priorities of the NIH HEAL Initiative. If, at any time, recruitment falls significantly below the projected milestones for recruitment, NIH will consider ending support and negotiating an orderly phaseout of the award. NIH retains the option of periodic external peer review of progress. NIH program staff will closely monitor progress at all stages for milestones, accrual, and safety.
Expected Activities of Coordination
NIH HEAL Initiative awardees are strongly encouraged to cooperate and coordinate their activities. It is expected that NIH HEAL Initiative awardees will cooperate and coordinate their activities after post award by participating in PD/PI meetings, including:
NIH HEAL Initiative Scientific Meeting Attendance
Applicants and students are highly encouraged to attend the annual NIH HEAL Initiative Scientific Meetings. The NIH HEAL Initiative hosts an annual meeting of more than 800 NIH HEAL Initiative-funded researchers across the initiatives research portfolio and career stage spectrum, NIH staff, people with lived and living experience, community partners advising initiative-funded projects, advocacy groups, and other stakeholders to
Annual National Pain Scientists Career Development Program (PURPOSE) Meeting
Applicants and students are also highly encouraged to enroll in the HEAL Initiative: Positively Uniting Researchers of Pain to Opine, Synthesize, and Engage (PURPOSE) network and attend its annual meetings. Details can be found at https://painresearchers.com . The HEAL R24 Coordinating Center for National Pain Scientists works to improve the collaboration between basic, translational, and clinical researchers who do not regularly collaborate or work together. One function of the HEAL R24 Coordinating Center for National Pain Scientists is to organize an annual meeting for established scientists as well as early-career pain investigators. This annual meeting facilitates the creation of a network of pain research mentors and mentees as well as fostering communication between scientists and clinicians of different disciplines and providing enhanced mentorship, leadership courses, and any additional training that might be helpful for early-career scientists. R15 recipients are encouraged to attend the annual PURPOSE meeting, either virtually or in person.
See Section VIII. Other Information for award authorities and regulations.
Plan for Enhancing Diverse Perspectives (PEDP) The NIH recognizes that teams comprised of investigators with diverse perspectives working together and capitalizing on innovative ideas and distinct viewpoints outperform homogeneous teams. There are many benefits that flow from a scientific workforce rich with diverse perspectives, including: fostering scientific innovation, enhancing global competitiveness, contributing to robust learning environments, improving the quality of the research, advancing the likelihood that underserved populations participate in, and benefit from research, and enhancing public trust. To support the best science, the NIH encourages inclusivity in research guided by the consideration of diverse perspectives. Broadly, diverse perspectives can include but are not limited to the educational background and scientific expertise of the people who perform the research; the populations who participate as human subjects in research studies; and the places where research is done. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Assessment of applications containing a PEDP are based on the scientific and technical merit of the proposed project. Consistent with federal law, the race, ethnicity, or sex (including gender identify, sexual orientation, or transgender status) of a researcher, award participant, or trainee will not be considered during the application review process or when making funding decisions. Applications that fail to include a PEDP will be considered incomplete and will be administratively withdrawn before review. The PEDP will be submitted as Other Project Information as an attachment (see Section IV). Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance materials .
Investigators proposing NIH-defined clinical trials may refer to the Research Methods Resources website for information about developing statistical methods and study designs.
Grant: A financial assistance mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.
The OER Glossary and the How to Apply - Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
Optional: Accepting applications that either propose or do not propose clinical trial(s).
Need help determining whether you are doing a clinical trial?
The NIH HEAL Initiative intends to commit an estimated total of $1.25 million to fund up to three awards per year for FY 2025, FY 2026, and FY 2027. Support for this funding opportunity is contingent upon annual NIH appropriations and the submission of a sufficient number of meritorious applications
Applicants may request up to $375,000 in direct costs for the entire project period. No more than one third of total project costs may go to non-R15-eligible institutions. Annual inflationary increases are not allowed.
The scope of the proposed project should determine the project period. The maximum project period is 3 years.
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
1. eligible applicants eligible organizations higher education institutions public/state controlled institutions of higher education private institutions of higher education the following types of higher education institutions are always encouraged to apply for nih support as public or private institutions of higher education: hispanic-serving institutions historically black colleges and universities (hbcus) tribally controlled colleges and universities (tccus) alaska native and native hawaiian serving institutions asian american native american pacific islander serving institutions (aanapisis) in addition, applicant organizations must meet the following criteria at the time of submission: the applicant organization must be an accredited public or nonprofit private school that grants baccalaureate or advanced degrees in health professions (see section below for more details) or biomedical and behavioral sciences. the application must be submitted by the eligible organization with a unique entity identifier (such as uei or duns) and a unique nih era institutional profile file (ipf) number. at the time of application submission, determination of eligibility will be based in part on nih institutional support. a year is defined as a federal fiscal year: from october 1 through september 30. note that collaborating subawardees do not need to adhere to the r15 eligibility criteria stated above. however, they must be separate legal entities that fulfill the terms of an eligible subaward agreement. for this particular nofo, they must also be u.s. domestic institutions. more details can be found at https://grants.nih.gov/policy/subawards . undergraduate focused institutions: at the time of application submission, all the non-health professional components of the institution combined must not have received support from the nih totaling more than $6 million per year (in both direct and f&a/indirect costs) in 4 of the last 7 years. for institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of nih funding received by all the non-health professional schools and colleges within the institution as a whole. note that all activity codes are included in this calculation except the following: c06, s10, and all activity codes starting with a g. help determining the organization funding level can be found at https://grants.nih.gov/grants/funding/determing-organization-funding-levels-r15-eligibility.pdf an academic component is any school/college that is not a health professional school or college. a qualifying academic component (i.e., school/college) within an institution (e.g., school of arts and sciences) has greater undergraduate student enrollment than graduate student enrollment. all types of health professional schools and colleges are not eligible to apply and are not considered in this calculation. for institutions with multiple campuses, eligibility can be considered for each individual campus (e.g., main, satellite, etc.) only if separate ueis and nih ipf numbers are established for each campus. for institutions that use one uei or nih ipf number for all campuses, eligibility is determined for all campuses (e.g., main, satellite, etc.) combined. health professional and graduate schools at the time of application submission, all components of the institution combined must not have received support from the nih totaling more than $6 million per year (in both direct and f&a/indirect costs) in 4 of the last 7 years. for institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of nih funding received by all of the schools and colleges within the institution as a whole. note that all activity codes are included in this calculation except the following: c06, s10, and all activity codes starting with a g. a graduate school offers advanced degrees, beyond the undergraduate level, in an academic discipline including m.a., m.s., and ph.d. degrees. health professional schools and colleges are accredited institutions that provide education and training leading to a health professional degree, including but not limited to: b.s.n., m.s.n., d.n.p., m.d., d.d.s., d.o., pharm.d., d.v.m., o.d., d.p.t., d.c., n.d., d.p.m., m.o.t., o.t.d., d.p.t., m.s.-s.l.p., c.sc.d., s.l.p.d., au.d., m.s.p.o., m.s.a.t., and m.p.h. eligible health professional schools/colleges may include schools or colleges of nursing, medicine, dentistry, osteopathy, pharmacy, veterinary medicine, public health, optometry, allied health, chiropractic, naturopathy, podiatry, rehabilitation medicine, physical therapy, orthotics and prosthetics, kinesiology, occupational therapy, and psychology. accreditation must be provided by a body approved for such purpose by the secretary of education. for institutions with multiple campuses, eligibility can be considered for each individual campus (e.g., main, satellite, etc.) only if a unique identifier number and nih ipf number are established for each campus. for institutions that use one identifier number or nih ipf number for all campuses, eligibility is determined for all campuses (e.g., main, satellite, etc.) together. additional eligibility guidance a signed letter is required from the provost or similar official with institution-wide responsibility verifying the eligibility of the applicant institution at the time of application submission according to the eligibility criteria indicated above. see the application instructions for other attachments on the sf424(r&r) other project information form in section iv.2 instructions for application submission. final eligibility will be validated by nih prior to award. to assist in determining eligibility, organizations are encouraged to use the nih report website under nih awards by location & organization . a prep application must provide evidence of a subaward to a separate institution , and the grantee may partner with a non-r15-eligible institution. however, applicants should keep the goals of the prep in mind when preparing the application, which include strengthening the research environment of eligible institutions and engaging students from eligible institutions in pain research. it is expected that the project, and two-thirds of the total project budget, will be directed by the pd(s)/pi(s) at r15-eligible institution(s). a letter of support from each collaborator is required verifying the research collaboration at the time of application submission according to the eligibility criteria indicated above. the letter(s) should detail how the proposed research partnership will help to accomplish the proposed pain research project, enhance the r15-eligible institutions research program, and promote synergy from an integrated, interdisciplinary research partnership(s) among the multiple proposed institutions. see the application instructions for other attachments on the sf424(r&r) other project information form in section iv.2 instructions for application submission. foreign organizations non-domestic (non-u.s.) entities (foreign organizations) are not eligible to apply. non-domestic (non-u.s.) components of u.s. organizations are not eligible to apply. foreign components, as defined in the nih grants policy statement , are allowed. required registrations applicant organizations applicant organizations must complete and maintain the following registrations as described in the how to apply - application guide to be eligible to apply for or receive an award. all registrations must be completed prior to the application being submitted. registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. failure to complete registrations in advance of a due date is not a valid reason for a late submission, please reference nih grants policy statement section 2.3.9.2 electronically submitted applications for additional information system for award management (sam) – applicants must complete and maintain an active registration, which requires renewal at least annually . the renewal process may require as much time as the initial registration. sam registration includes the assignment of a commercial and government entity (cage) code for domestic organizations which have not already been assigned a cage code. nato commercial and government entity (ncage) code – foreign organizations must obtain an ncage code (in lieu of a cage code) in order to register in sam. unique entity identifier (uei) - a uei is issued as part of the sam.gov registration process. the same uei must be used for all registrations, as well as on the grant application. era commons - once the unique organization identifier is established, organizations can register with era commons in tandem with completing their grants.gov registrations; all registrations must be in place by time of submission. era commons requires organizations to identify at least one signing official (so) and at least one program director/principal investigator (pd/pi) account in order to submit an application. grants.gov – applicants must have an active sam registration in order to complete the grants.gov registration. program directors/principal investigators (pd(s)/pi(s)) all pd(s)/pi(s) must have an era commons account. pd(s)/pi(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in era commons. if the pd/pi is also the organizational signing official, they must have two distinct era commons accounts, one for each role. obtaining an era commons account can take up to 2 weeks. eligible individuals (program director/principal investigator) any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the program director(s)/principal investigator(s) (pd(s)/pi(s)) is invited to work with their organization to develop an application for support. individuals from diverse backgrounds, including individuals from underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for nih support. see, reminder: notice of nih's encouragement of applications supporting individuals from underrepresented ethnic and racial groups as well as individuals with disabilities , not-od-22-019 . for institutions/organizations proposing multiple pds/pis, visit the multiple program director/principal investigator policy and submission details in the senior/key person profile (expanded) component of the how to apply - application guide . to be eligible for support under a prep grant, the pd(s)/pi(s) must meet the following additional criteria: each pd/pi must have a primary appointment at either an r15-eligible institution, including professional or graduate schools, undergraduate-focused organizations, or a college within the applicant institution, as defined in eligible organizations, above. if proposing multiple pd(s)/pi(s), each pd/pi must be at an r15-eligible institution. each pd/pi may not be the pd/pi of an active nih research grant, including another r15 grant, at the time of award of a prep grant, although they may be one of the key personnel for an active nih grant held by another pd/pi. each pd/pi may not be awarded support under more than one r15 grant at a time, although he or she may have support under successive new or renewal grants. 2. cost sharing.
This NOFO does not require cost sharing as defined in the NIH Grants Policy Statement NIH Grants Policy Statement Section 1.2 Definition of Terms.
Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct.
The NIH will not accept duplicate or highly overlapping applications under review at the same time, per NIH Grants Policy Statement Section 2.3.7.4 Submission of Resubmission Application . This means that the NIH will not accept:
1. requesting an application package.
The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this NOFO. See your administrative office for instructions if you plan to use an institutional system-to-system solution.
It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide except where instructed in this notice of funding opportunity to do otherwise. Conformance to the requirements in the How to Apply - Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information , prospective applicants are asked to submit a letter of intent that includes the following information:
The letter of intent should be sent to:
Jessica McKlveen, PhD National Center for Complementary & Integrative Health (NCCIH) Telephone: 301-594-8018 Email: [email protected]
All page limitations described in the How to Apply – Application Guide and the Table of Page Limits must be followed.
The following section supplements the instructions found in the How to Apply – Application Guide and should be used for preparing an application to this NOFO.
All instructions in the How to Apply - Application Guide must be followed.
Sf424(r&r) other project information.
Facilities & Other Resources (Required):
Applications without a Facilities & Other Resources document will be withdrawn.
Other Attachments:
Applications that fail to include the following three required ‘other attachments will be considered incomplete and will be withdrawn.
1.Team Management Plan (Required three pages maximum):
A key goal of this program is to establish new research partnerships among R15-eligible investigators and other domestic research centers, programs, or institutions with complementary research expertise and/or resources. To ensure that prospective research teams fit the goals of the PREP, a team management plan is required. Applications with team management plans that exceed the three-page limit will be withdrawn.
As an Other Attachment entitled Team-Management-Plan.pdf, applications should describe how the research collaborators will function to accomplish program objectives. Team management approaches raised in the subsections listed below should be described in the plan. Note that a Multiple PD/PI Leadership Plan may also be submitted as a separate attachment, and if it is included the information in that plan should not be duplicated here. Whereas the Multiple PD/PI Leadership Plan focuses on leadership by and interactions across the PD/PIs, the Team Management Plan focuses on management of the whole team/key personnel. Applicants are encouraged to consult resources to aid in developing effective team-based programs (see e.g., the NCI Collaboration and Team Science Field Guide ).
Organizational structure and team composition: The Team Management Plan should clearly show the organizational structure and composition of the proposed project team. Two-thirds of the proposed research project team should be health professional students trainees or graduate students or undergraduate from the primary R15-eligible institution. The plan should describe a management structure based on project objectives that effectively promote the proposed research. The structure should account for team composition, institutional resources, and policies that conform with PREP objectives outlined in Section I.
Shared leadership, contributions, and distributed responsibility for decision-making: The Team Management Plan should include a description of how the proposed collaborators will work together to direct the overall scientific team to leverage the diverse perspectives, expertise, and skills of the team members to successfully accomplish the goals of the project. One key consideration is that teams employing multidisciplinary approaches and having diverse areas of intellectual and technical expertise are more productive if the process for making decisions incorporates different points of view. The Team Management Plan should describe how major decisions will be made or how conflicts will be resolved.
Resource sharing and allocation across the team: Applications should describe management and decision-making processes that promote collective input for allocation of program resources with flexibility when resources may need to be dynamically reallocated to achieve programmatic goals. A plan for how intra-team, institutional, and regional resources that are integral to the team goals will be shared and made accessible to team members should also be included.
Credit assignment: A plan for how credit and IP will be shared, especially with the R15 institutions students, should be included. Methods for attributing contributions to publications should be described to enable individual professional assessment in joint projects.
Coordination and communication plans: Practical aspects should be described, including frequency and logistics of real-time communication across all key personnel, consultants, scholars, early-stage investigators etc., and other significant contributors regardless of effort level.
An important and meaningful impact of team science may come from shaping the next generation of pain scientists. Because of the interdisciplinary expertise of the research groups, students are exposed to and can learn a variety of scientific approaches and methodologies, resulting in multifaceted early-stage investigators. Plans for how students trainees will be immersed in and benefit from different approaches taken by the collective team program should be described. This could include shared mentorship, inter-laboratory meetings, all-hands tutorials, shared meeting and document space, inter-laboratory visits, and student presentations.
2. Provost Letter(s) of Support: The application must include a PDF-formatted letter named ProvostLetter.pdf (without quotation marks). For MPI applications a signed provost letter is required from each involved institution. The letter must be signed by the provost or similar official with institution-wide responsibility attesting to the following information:
For Undergraduate Focused Institutions:
For Health Professional and Graduate Schools:
3. Collaborator Letter(s) of Support: Applications must include additional PDF-formatted letter(s) from collaborating subaward holder(s) named CollaboratorLetter_ Initials .pdf (without quotation marks). For multiple collaborators, a signed letter is required from each involved collaborator. Note that collaborators do not need to meet the R15-eligibility criteria outlined above. The letter should demonstrate the collaborator's willingness to collaborate with the study lead as well as briefly outline their contributions to the project that will result in a well-integrated, interdisciplinary research approach to the understanding of pain. If the proposed collaboration is a new research partnership among investigators, this information should also be included.
Plan for Enhancing Diverse Perspectives (PEDP)
Examples of items that advance inclusivity in research and may be appropriate for a PEDP can include, but are not limited to:
Examples of items that are not appropriate in a PEDP include, but are not limited to:
For further information on the Plan for Enhancing Diverse Perspectives (PEDP), please see PEDP guidance materials .
R&r or modular budget.
Budget Justification:
Personnel Justification: Since a primary objective of the PREP is to expose and incorporate students into multidisciplinary pain research, PD(s)/PI(s) must include health professional or undergraduate and/or graduate students from the applicant institution/applicant component in the proposed research. Students from the R15-eligible institution should compose the majority of the research team (two thirds or more). Indicate aspects of the proposed research in which students will participate. If participating students have not yet been identified, the number and academic level of those to be involved should be provided. Collaborators or consultants for the project should provide additional budget information, including their names, their organizational affiliations, and the services they will perform.
PEDP implementation costs: Applicants may include allowable costs associated with PEDP implementation (as outlined in the Grants Policy Statement section 7): https://grants.nih.gov/grants/policy/nihgps/html5/section_7/7.1_general.htm.
Phs 398 cover page supplement, phs 398 research plan.
All instructions in the How to Apply - Application Guide must be followed, with the following additional instructions:
Research Strategy:
The research strategy must address how the proposed project intends to accomplish all three objectives of this program, including: 1) Supporting the efforts by R15-eligible principal investigators (PIs) at undergraduate-focused institutions OR health professional schools and graduate schools to conduct small-scale basic and mechanistic pain research; (2) promoting integrated, interdisciplinary research partnerships between R15-eligible PIs and additional investigators from U.S. domestic institutions; and (3) enhancing the pain research environment at the R15-eligible institution for health professional students or undergraduate and/or graduate students by actively engaging them in the proposed pain research projects.
Applications should include a detailed description of a research approach that will produce rigorous data that can be disseminated and advance our basic and mechanistic understanding of pain. Additionally, the research strategy should detail how the proposed research partnership includes sufficient integrative pain expertise and related resources and/or institutional infrastructure that increase the likelihood of success. The application should detail how the proposed scientific research and proposed program and research partnership will have a substantial effect on strengthening the research environment at the proposed applicants institution.
Applications should provide details on how the research project will be directed by the R15-eligible PI and how two-thirds of the research project will be conducted at the R15-eligible institution. The research strategy should detail how the research team will recruit additional prospective investigators, including students, from a range of backgrounds, skills, and expertise for the broad pool of researchers who may apply to participate and contribute to the project. Applications should include details about how the investigators will cooperate and coordinate their activities with other HEAL investigators at PD/PI meetings, including (but not limited to) other investigators in the R15 program, the HEAL Annual Scientific and PURPOSE meetings.Proposed PD/PI(s) should include evidence of experience supervising students in previous research efforts, as well as describing any innovative approaches to engage students in the proposed pain research project. Applications should provide additional details outlining student involvement in the research project by addressing the following questions:
Resource Sharing Plan : Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the How to Apply - Application Guide .
Other Plan(s):
All instructions in the How to Apply - Application Guide must be followed, with the following additional instructions:
The NIH HEAL Initiative has additional requirements that must be addressed in the Data Management and Sharing Plan. All HEAL-generated data must be shared through the HEAL Initiative Data Ecosystem following HEALs compliance guidance ( https://heal.nih.gov/data/complying-heal-data-sharing-policy ). Specifically, HEAL applicants must include:
The NIH HEAL Initiative has developed additional details and resources to fulfill these requirements ( https://www.healdatafair.org/resources/road-map ). Budgeting guidance for data sharing can be found in NOT-OD-21-015 and the NIH Scientific Data Sharing site .
Appendix: Only limited Appendix materials are allowed. Follow all instructions for the Appendix as described in the How to Apply - Application Guide .
When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the How to Apply - Application Guide , with the following additional instructions:
If you answered Yes to the question Are Human Subjects Involved? on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.
Study Record: PHS Human Subjects and Clinical Trials Information
Section 2 - Study Population Characteristics
2.5 Recruitment and Retention Plan
Describe the following:
2.7 Study Timeline
Include a table or graph of the overall study timeline. This is expected to be a visual representation (such as a Gantt chart) of recruitment milestones and key project management activities. A narrative is not expected in this section.
The study timeline should include recruitment milestones that need to be met throughout the life cycle of the clinical trial to ensure its success, and the subtasks that will be used to reach the recruitment milestones. In the timeline, the study duration is expected to be displayed in months. The timeline should include, but is not limited to, the following:
(a) When the study opens to enrollment (b) When recruitment milestones (see below) are met (c) What subtasks are needed to reach of the recruitment milestones (d) When final transfer of the data will occur (e) When analysis of the study data will occur (f) When the primary study manuscript will be submitted for publication
Delayed Onset Study
Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start). All instructions in the How to Apply - Application Guide must be followed.
3. unique entity identifier and system for award management (sam).
See Part 2. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov
Part I. contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday , the application deadline is automatically extended to the next business day.
Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons , NIHs electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Grants Policy Statement Section 2.3.9.2 Electronically Submitted Applications .
Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.
Information on the submission process and a definition of on-time submission are provided in the How to Apply – Application Guide .
This initiative is not subject to intergovernmental review.
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement .
Pre-award costs are allowable only as described in the NIH Grants Policy Statement Section 7.9.1 Selected Items of Cost .
Applications must be submitted electronically following the instructions described in the How to Apply - Application Guide . Paper applications will not be accepted.
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply – Application Guide . If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII .
Important reminders:
All PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile form . Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH. See Section III of this NOFO for information on registration requirements.
The applicant organization must ensure that the unique entity identifier provided on the application is the same identifier used in the organizations profile in the eRA Commons and for the System for Award Management. Additional information may be found in the How to Apply - Application Guide .
See more tips for avoiding common errors.
Applications must include a PEDP submitted as Other Project Information as an attachment. Applications that fail to include a PEDP will be considered incomplete and will be administratively withdrawn before review.
Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review and responsiveness by components of participating organizations , NIH. Applications that are incomplete, non-compliant and/or nonresponsive will not be reviewed.
In order to expedite review, applicants are requested to notify the NCCIH Referral Office by email at [email protected] when the application has been submitted. Please include the NOFO and title, PD/PI name, and title of the application.
Recipients or subrecipients must submit any information related to violations of federal criminal law involving fraud, bribery, or gratuity violations potentially affecting the federal award. See Mandatory Disclosures, 2 CFR 200.113 and NIH Grants Policy Statement Section 4.1.35 .
Send written disclosures to the NIH Chief Grants Management Officer listed on the Notice of Award for the IC that funded the award and to the HHS Office of Inspector Grant Self Disclosure Program at [email protected] .
Applicants are required to follow the instructions for post-submission materials, as described in the policy
The following post-submission materials will be accepted: Team Management Plan (e.g., due to the hiring, replacement, or loss of an investigator).
1. criteria.
Only the review criteria described below will be considered in the review process. Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.
For this particular NOFO, note the following:
The purpose of this HEAL Initiative program is to (1) support the efforts by R15-eligible principal investigators (PIs) at primarily undergraduate-focused serving institutions or health professional schools and graduate schools to conduct small-scale basic and mechanistic pain research projects ; (2) promote integrated, interdisciplinary research partnerships between R15-eligible PIs and investigators from U.S. domestic institutions; and (3) enhance the pain research environment at the R15-eligible institution for health professional students or undergraduate and/or graduate students by actively engaging them in the proposed pain research projects.
Applications in response to this notice of funding opportunity (NOFO) should include plans to accomplish these goals. Specifically, applications should include a rigorous plan for conducting basic and mechanistic pain research projects in the Research Strategy section of the application . In addition, a research partnership between the PIs institution and at least one investigator from a separate U.S. domestic institution that provides resources and/or expertise that will enhance the proposed pain research program must be included in a separate Team Management Plan. The proposed partnership will be a sub-award agreement(s) with at least one partnering institution, which does not need to be R15-eligible. The budget of all sub-awards must not exceed one third of the total budget. Furthermore, applications must include a Facilities & Other Resources document that demonstrates active involvement of health professional students or undergraduate and/or graduate students from the R15-eligible institution(s) in the proposed pain research projects.
Although preliminary data are not required for an R15 application, they may be included if available. The scientific foundation for the proposed research should be based on published research and/or any available preliminary data.
A proposed Clinical Trial application may include study design, methods, and intervention that are not by themselves innovative but address important questions or unmet needs. Additionally, the results of the clinical trial may indicate that further clinical development of the intervention is unwarranted or lead to new avenues of scientific investigation.
Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).As part of the overall impact score, reviewers should consider and indicate how the Plan for Enhancing Diverse Perspectives affects the scientific merit of the project.
Reviewers will consider each of the review criteria below in the determination of scientific merit and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Does the project address an important problem or a critical barrier to progress in the field? Is the prior research that serves as the key support for the proposed project rigorous? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
In addition, for applications involving clinical trials
Are the scientific rationale and need for a clinical trial to test the proposed hypothesis or intervention well supported by preliminary data, clinical and/or preclinical studies, or information in the literature or knowledge of biological mechanisms? For trials focusing on clinical or public health endpoints, is this clinical trial necessary for testing the safety, efficacy or effectiveness of an intervention that could lead to a change in clinical practice, community behaviors or health care policy? For trials focusing on mechanistic, behavioral, physiological, biochemical, or other biomedical endpoints, is this trial needed to advance scientific understanding?
Specific to this NOFO:
Taking into consideration the type of R15-eligible institution the application has been submitted from, if funded, will this grant have a substantial effect on strengthening the research environment at the applicant institution and exposing students to research ?
Does the project adequately describe how the research partnership will advance our understanding of pain conditions?
If the aims of the project are achieved, will the project yield rigorous data that can be disseminated and is likely to be important to the field?
Will the proposed collaboration appropriately improve the R15 institutional environment in a manner to support more students to engage in pain research at that institution?
Are the PD(s)/PI(s), collaborators, and other researchers well suited to the project? If Early Stage Investigators or those in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?
With regard to the proposed leadership for the project, do the PD/PI(s) and key personnel have the expertise, experience, and ability to organize, manage and implement the proposed clinical trial and meet milestones and timelines? Do they have appropriate expertise in study coordination, data management and statistics? For a multicenter trial, is the organizational structure appropriate and does the application identify a core of potential center investigators and staffing for a coordinating center?
Does the application provide details about how the research project will be directed by the R15-eligible PI and how two-thirds of the research project will be conducted at the R15-eligible institution?
Is it clear how the applicant intends to recruit additional prospective investigators, including students, from a range of backgrounds, skills, and expertise for the pool of researchers who may apply to address the proposed scientific problem?
Will the combined scientific expertise (of the proposed collaborative research team) likely result in a well-integrated, interdisciplinary research approach to the understanding of pain?
Does the team of investigators include sufficient integrative pain expertise for the proposed research?
How appropriate is the PD/PI's experience in supervising and engaging students in research?
Does the application include details about how the investigators will cooperate and coordinate their activities with other HEAL investigators at PD/PI meetings, including (but not limited to) other investigators in the R15 program, the HEAL Annual Scientific and PURPOSE meetings?
Team Management Plan (Attachment):
How fair and adequate are the governance processes for decision making, conflict resolution, and resource allocation outlined in the plan?
How effective is the plan for team leadership and management with sufficient examples of distributed responsibility?
How well would the program leadership create a sustainable environment for maintaining cohesiveness, productivity, and shared vision?
How adequate are the management plans for shared professional credit?
If shared research resources will be utilized, how adequate are the plans for resource sharing and allocation to ensure that all team members will have the access they require?
How well does the plan include examples of team coordination and communication?
How clearly does the plan include details about which personnel are available at the R15-eligible institution(s), including health professional students or graduate students or undergraduate students, that would compose a two-thirds majority of the project team and how they would contribute to the research project?
How well does the management plan outline how the collaborative partnership will supervise and engage students?
Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
Does the design/research plan include innovative elements, as appropriate, that enhance its sensitivity, potential for information or potential to advance scientific knowledge or clinical practice?
Does the proposed research include innovative interdisciplinary pain research topics?
Is the proposed research partnership a new collaboration between investigators?
Are innovative approaches for engaging health professional or undergraduate and/or graduate students in research proposed?
Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Have the investigators included plans to address weaknesses in the rigor of prior research that serves as the key support for the proposed project? Have the investigators presented strategies to ensure a robust and unbiased approach, as appropriate for the work proposed? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed? Have the investigators presented adequate plans to address relevant biological variables, such as sex, for studies in vertebrate animals or human subjects?
If the project involves human subjects and/or NIH-defined clinical research, are the plans to address 1) the protection of human subjects from research risks, and 2) inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion or exclusion of individuals of all ages (including children and older adults), justified in terms of the scientific goals and research strategy proposed?
Does the application adequately address the following, if applicable
Study Design
Is the study design justified and appropriate to address primary and secondary outcome variable(s)/endpoints that will be clear, informative and relevant to the hypothesis being tested? Is the scientific rationale/premise of the study based on previously well-designed preclinical and/or clinical research? Given the methods used to assign participants and deliver interventions, is the study design adequately powered to answer the research question(s), test the proposed hypothesis/hypotheses, and provide interpretable results? Is the trial appropriately designed to conduct the research efficiently? Are the study populations (size, gender, age, demographic group), proposed intervention arms/dose, and duration of the trial, appropriate and well justified?
Are potential ethical issues adequately addressed? Is the process for obtaining informed consent or assent appropriate? Is the eligible population available? Are the plans for recruitment outreach, enrollment, retention, handling dropouts, missed visits, and losses to follow-up appropriate to ensure robust data collection? Are the planned recruitment timelines feasible and is the plan to monitor accrual adequate? Has the need for randomization (or not), masking (if appropriate), controls, and inclusion/exclusion criteria been addressed? Are differences addressed, if applicable, in the intervention effect due to sex/gender and race/ethnicity?
Are the plans to standardize, assure quality of, and monitor adherence to, the trial protocol and data collection or distribution guidelines appropriate? Is there a plan to obtain required study agent(s)? Does the application propose to use existing available resources, as applicable?
Data Management and Statistical Analysis
Are planned analyses and statistical approach appropriate for the proposed study design and methods used to assign participants and deliver interventions? Are the procedures for data management and quality control of data adequate at clinical site(s) or at center laboratories, as applicable? Have the methods for standardization of procedures for data management to assess the effect of the intervention and quality control been addressed? Is there a plan to complete data analysis within the proposed period of the award?
Taking into consideration the type of R15-eligible institution the application has been submitted from, how suitable are the plans for ensuring that students are well integrated into the research program?
How will this project provide students with a high-quality research experience focused on the execution, analysis, and reporting of the study?
Would students have adequate opportunities to present at national or local meetings, publish research findings, and/or participate in other collaborative activities?
Would the proposed research project provide adequate opportunities for students to improve their research capabilities and support their progress toward a biomedical research career?
Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
If proposed, are the administrative, data coordinating, enrollment and laboratory/testing centers, appropriate for the trial proposed?
Does the application adequately address the capability and ability to conduct the trial at the proposed site(s) or centers? Are the plans to add or drop enrollment centers, as needed, appropriate?
If international site(s) is/are proposed, does the application adequately address the complexity of executing the clinical trial?
If multi-sites/centers, is there evidence of the ability of the individual site or center to: (1) enroll the proposed numbers; (2) adhere to the protocol; (3) collect and transmit data in an accurate and timely fashion; and, (4) operate within the proposed organizational structure?
Does the "Facilities & Other Resources" attachment describe strong and innovative approaches to how students or trainees will participate in the research project?
Does the application demonstrate appropriate plans to recruit health professional or undergraduate and/or graduate students from diverse backgrounds to participate in the research project?
Does the application provide a plan to aid students at the R15-eligible institution/academic component to pursue careers in the biomedical sciences?
Do(es) the PD/PI(s) have sufficient time and institutional support to conduct the proposed project?
Is there synergy to be gained from the integrated, interdisciplinary research partnership(s) among the multiple proposed institutions?
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.
Specific to applications involving clinical trials
Is the study timeline described in detail, taking into account start-up activities, the anticipated rate of enrollment, and planned follow-up assessment? Is the projected timeline feasible and well justified? Does the project incorporate efficiencies and utilize existing resources (e.g., CTSAs, practice-based research networks, electronic medical records, administrative database, or patient registries) to increase the efficiency of participant enrollment and data collection, as appropriate?
Are potential challenges and corresponding solutions discussed (e.g., strategies that can be implemented in the event of enrollment shortfalls)?
Specific to this NOFO: Are the clinical trial recruitment milestones feasible given the proposed study timeline?
For research that involves human subjects but does not involve one of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or more of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects .
When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of individuals of all ages (including children and older adults) to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research .
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following three points: (1) a complete description of all proposed procedures including the species, strains, ages, sex, and total numbers of animals to be used; (2) justifications that the species is appropriate for the proposed research and why the research goals cannot be accomplished using an alternative non-animal model; and (3) interventions including analgesia, anesthesia, sedation, palliative care, and humane endpoints that will be used to limit any unavoidable discomfort, distress, pain and injury in the conduct of scientifically valuable research. Methods of euthanasia and justification for selected methods, if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals, is also required but is found in a separate section of the application. For additional information on review of the Vertebrate Animals Section, please refer to the Worksheet for Review of the Vertebrate Animals Section.
Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.
Not applicable.
Not applicable.
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.
Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Reviewers will comment on whether the Resource Sharing Plan(s) (e.g., Sharing Model Organisms ) or the rationale for not sharing the resources, is reasonable.
For projects involving key biological and/or chemical resources, reviewers will comment on the brief plans proposed for identifying and ensuring the validity of those resources.
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons . Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.
Information regarding the disposition of applications is available in the NIH Grants Policy Statement Section 2.4.4 Disposition of Applications .
1. award notices.
A Notice of Award (NoA) is the official authorizing document notifying the applicant that an award has been made and that funds may be requested from the designated HHS payment system or office. The NoA is signed by the Grants Management Officer and emailed to the recipients business official.
In accepting the award, the recipient agrees that any activities under the award are subject to all provisions currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.
Recipients must comply with any funding restrictions described in Section IV.6. Funding Restrictions . Any pre-award costs incurred before receipt of the NoA are at the applicant's own risk. For more information on the Notice of Award, please refer to the NIH Grants Policy Statement Section 5. The Notice of Award and NIH Grants & Funding website, see Award Process.
Individual awards are based on the application submitted to, and as approved by, the NIH and are subject to the IC-specific terms and conditions identified in the NoA.
ClinicalTrials.gov: If an award provides for one or more clinical trials. By law (Title VIII, Section 801 of Public Law 110-85), the "responsible party" must register and submit results information for certain applicable clinical trials on the ClinicalTrials.gov Protocol Registration and Results System Information Website ( https://register.clinicaltrials.gov ). NIH expects registration and results reporting of all trials whether required under the law or not. For more information, see https://grants.nih.gov/policy/clinical-trials/reporting/index.htm
Institutional Review Board or Independent Ethics Committee Approval: Recipient institutions must ensure that all protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in NIH-funded studies, the recipient must provide NIH copies of documents related to all major changes in the status of ongoing protocols.
Data and Safety Monitoring Requirements: The NIH policy for data and safety monitoring requires oversight and monitoring of all NIH-conducted or -supported human biomedical and behavioral intervention studies (clinical trials) to ensure the safety of participants and the validity and integrity of the data. Further information concerning these requirements is found at http://grants.nih.gov/grants/policy/hs/data_safety.htm and in the application instructions (SF424 (R&R) and PHS 398).
Investigational New Drug or Investigational Device Exemption Requirements: Consistent with federal regulations, clinical research projects involving the use of investigational therapeutics, vaccines, or other medical interventions (including licensed products and devices for a purpose other than that for which they were licensed) in humans under a research protocol must be performed under a Food and Drug Administration (FDA) investigational new drug (IND) or investigational device exemption (IDE).
The following Federal wide and HHS-specific policy requirements apply to awards funded through NIH:
All federal statutes and regulations relevant to federal financial assistance, including those highlighted in NIH Grants Policy Statement Section 4 Public Policy Requirements, Objectives and Other Appropriation Mandates.
Recipients are responsible for ensuring that their activities comply with all applicable federal regulations. NIH may terminate awards under certain circumstances. See 2 CFR Part 200.340 Termination and NIH Grants Policy Statement Section 8.5.2 Remedies for Noncompliance or Enforcement Actions: Suspension, Termination, and Withholding of Support .
Consistent with the 2023 NIH Policy for Data Management and Sharing, when data management and sharing is applicable to the award, recipients will be required to adhere to the Data Management and Sharing requirements as outlined in the NIH Grants Policy Statement . Upon the approval of a Data Management and Sharing Plan, it is required for recipients to implement the plan as described.
HEAL Data Sharing Requirements
NIH intends to maximize the impact of NIH HEAL Initiative-supported projects through broad and rapid data sharing. All NIH HEAL Initiative award recipients, regardless of the amount of direct costs requested for any one year, are required to comply with the HEAL Public Access and Data Sharing Policy. NIH HEAL Initiative award recipients must follow all requirements and timelines developed through the HEAL Initiative Data Ecosystem ( https://heal.nih.gov/about/heal-data-ecosystem ), as described in the initiatives compliance guidance (See Already Funded section: https://heal.nih.gov/data/complying-heal-data-sharing-policy ):
1. Select a HEAL-compliant data repository ( https://www.healdatafair.org/resources/guidance/selection )
2. Within one year of award, register your study with the HEAL platform ( https://heal.github.io/platform-documentation/study-registration/ )
3. Within one year of award, submit HEAL-specific study-level metadata.
4. Submit data and metadata (and code, if applicable) to HEAL-compliant repository
6. Additional Requirements for NIH HEAL Initiative studies conducting clinical research or research involving human subjects.
These studies must meet the following additional requirements:
Additional details, resources, and tools to assist with data-related activities can be found at https://www.healdatafair.org . Budgeting guidance for data sharing can be found in NOT-OD-21-015 and the NIH Scientific Data Sharing site .
All data collected as part of the NIH HEAL Initiative are collected under a Certificate of Confidentiality and entitled to the protections thereof. Institutions who receive data and/or materials from this award for performance of activities under this award are required to use the data and/or materials only as outlined by the NIH HEAL Initiative, in a manner that is consistent with applicable state and Federal laws and regulations, including any informed consent requirements and the terms of the institutions NIH funding, including NOT-OD-17-109 and 42 U.S.C. 241(d). Failure to adhere to this criterion may result in enforcement actions.
Progress reports for multi-year funded awards are due annually on or before the anniversary of the budget/project period start date of award. The reporting period for multi-year funded award progress report is the calendar year preceding the anniversary date of the award. Information on the content of the progress report and instructions on how to submit the report using the RPPR are posted at http://grants.nih.gov/grants/policy/myf.htm
( To follow the next section ):
Report and ensure immediate public access to HEAL-funded publications
Publications resulting from NIH HEAL Initiative-funded studies must be immediately publicly available upon publication.
Prior to publication, the NIH HEAL Initiative expects investigators to alert their program officers of upcoming manuscripts to ensure coordination of communication and outreach efforts.
Award recipients and their collaborators are required to acknowledge NIH HEAL Initiative support by referencing in the acknowledgment sections of any relevant publication:
This research was supported by the National Institutes of Health through the NIH HEAL Initiative ( https://heal.nih.gov ) under award number [include specific grant/contract/award number; with NIH grant number(s) in this format: R01GM987654].
A final RPPR, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement Section 8.6 Closeout . NIH NOFOs outline intended research goals and objectives. Post award, NIH will review and measure performance based on the details and outcomes that are shared within the RPPR, as described at 2 CFR Part 200.301.
We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.
eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)
Finding Help Online: https://www.era.nih.gov/need-help (preferred method of contact) Telephone: 301-402-7469 or 866-504-9552 (Toll Free)
General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources) Email: [email protected] (preferred method of contact) Telephone: 301-480-7075
Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace) Contact Center Telephone: 800-518-4726 Email: [email protected]
Alex Tuttle, Ph.D. National Center for Complementary and Integrative Health (NCCIH) Phone: 301-814-6115 Email: [email protected]
Mark Egli, Ph.D. National Institute on Alcohol Abuse and Alcoholism (NIAAA) Phone: 301-594-6382 E-mail: [email protected]
Rebecca N Lenzi, Ph.D. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES (NIAMS) Phone: (301) 402-2446 E-mail: [email protected]
Rene Etcheberrigaray, M.D. National Institute on Aging (NIA) Phone: 301-451-9798 Email: [email protected]
Susan Marden, PhD, RN Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Telephone: 301-435-6838 Email: [email protected]
Elizabeth Sypek, PhD National Institute of Neurological Disorders and Stroke (NINDS) Email: [email protected]
Examine your eRA Commons account for review assignment and contact information (information appears 2 weeks after the submission due date).
Debbie Chen National Center for Complementary and Integrative Health (NCCIH) Phone: 301-594-3788 Email: [email protected]
Judy Fox National Institute on Alcohol Abuse and Alcoholism (NIAAA) Telephone: 301-443-4704 Email: [email protected]
Erik Edgerton NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES (NIAMS) Phone: 301-594-7760 E-mail: [email protected]
Ryan Blakeney National Institute on Aging (NIA) Phone: 301-451-9802 Email: [email protected]
Margaret Young Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Telephone: 301-642-4552 Email: [email protected]
Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts . All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement .
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
COMMENTS
It should also outline the research objectives, methods, and expected outcomes. Here is a basic template for a postdoctoral research proposal: I. Introduction. Provide a brief overview of the research area and context for your proposed research. State the research problem or question that your project will address.
NSF and Ford. NSF funds some postdoctoral fellowships (see specific programs) and research grants. Ford: "The awards will be made to individuals who, in the judgment of the review panels, have demonstrated superior academic achievement, are committed to a career in teaching and research at the college or university level, show promise of ...
which to develop the non-academic impact of my research and advance my expertise in using interactive documentary as an impact and engagement tool. 1.4. Impact plan and user engagement As explained in the objectives and summary sections, the Fellowship is designed to maximise impact and user engagement in the following ways:
Postdoctoral fellowships can solve many of these problems because they provide the freedom to choose the research topic, PI, and/or location (though these details often need to be declared before submitting an application). Of course, the odds of receiving postdoctoral fellowships are not high (typically single digit percentages).
There are also postdoc positions (e.g., British Academy Postdoctoral Fellowships, Leverhulme Early Career Fellowships, Mind/Analysis Studentships, various JRFs at Oxford/Cambridge colleges) where areas of research are unrestricted. Writing a postdoc research proposal is almost nothing like writing a paper for journal publication.
The Big Picture. When put all together, a postdoc research proposal includes a table of contents, an abstract, an introduction, a problem statement and hypothesis/objectives, a literature review, the research methods, a timetable, the expected results, appendices (if necessary), and references. Make sure that you get feedback early and often ...
fellowship to support me and 8 other candidates in the writing process. Step four: select your supervisor(s) The supervisor's profile is an important part of your proposal and their CV can influence
AHA Postdoctoral Fellowship Proposed Research Plan Outline 5-page document, including Specific Aims. Please use the below as a suggested outline and adapt to best fit your own proposal. Format A A. Specific Aims: Try to limit to 1-page at most. Include brief overview of background to appreciate the aims, knowledge gaps, and central hypothesis
Go to: Rule 1: Start Early and Gather Critical Information. Crafting a competitive fellowship can take 6-9 months, so it is imperative that you start early. You may even want to start looking for postdoctoral fellowships before you finish your doctoral degree. Compile a comprehensive list of fellowships that you can apply to.
The award amount is $180,000 over 2 years for salary, fringe benefits and research expenditures; instrumentation fellowships will receive an additional one-time amount of up to $100,000. Fellows receiving year 3 renewal award will receive additional $90,000. Banting Postdoctoral Fellowships.
1. Obtain a doctoral degree. One of the most important requirements to become a postdoctoral research fellow is obtaining a doctoral degree. You can obtain a Doctor of Philosophy (Ph.D.), Doctor of Medicine (M.D.) or a Doctor of Dental Surgery (D.D.S.). A doctoral degree typically follows a master's program, which follows a bachelor's program.
postdoctoral fellowship, establish a research plan and discuss long-term research and career goals. During or after this meeting, consider completing this form and preparing a photocopy for both supervisor and trainee. 1. Outline below the fellow's long-term research plan, including potential problems and alternative approaches. 2.
Funded by NSF, the Innovative Postdoctoral Entrepreneurial Research Fellowship (I-PERF) recruits, trains, mentors, matches and funds early-career, Ph.D.-level scientists and engineers so they can participate in innovative entrepreneurial activities at some of the nation's most promising startup companies. Fellows receive an annual stipend of ...
should fit the proposed project, Cornell's goals, and the needs of the post-doctoral researcher. You are encouraged to use this template as a guide to create your own plan. NSF requires a postdoctoral mentoring plan for all proposals requesting fund-ing for postdoctoral researchers' salaries. However, the information included
The program offers 18-month postdoctoral fellowships with 12 months spent at the scholars' home institution and six months spent in stipend-supported residency at Harvard University. APPLICATIONS FOR THE 2024-2026 COHORT WILL OPEN FRIDAY, MARCH 1, 2024. APPLICATION DEADLINE: APRIL 30, 2024.
Our Postdoctoral Research Fellow Program aims to be a best-in-industry experience for PhD graduates, providing academic focus in a large pharmaceutical environment. With Merck's resources, reach and expertise at their fingertips, our postdoctoral fellows work under the mentorship of our dedicated researchers and alongside a diverse team of ...
Postdoctoral Training and Opportunities. Postdoctoral associates and fellows are an essential part of scientific advancement and research. The Yale School of Public Health has an abundance of postdoctoral positions at any given time in multiple disciplines. Following are some of our ongoing opportunities for early career researchers.
The AHA 's annual stipend matches the published NIH sliding scale for postdoctoral fellows at the time the AHA begins to accept proposals (July 1, 2024) A minimum of $1,500 per year must be spent on travel to a national conference (attendance at AHA Scientific Sessions is strongly encouraged). International travel is permitted and does not ...
An IDP for postdoctoral fellows provides a means for the PI and postdoc to work together to: Identify short- and long-term career goals and discussion of time frame for fellowship completion. Define milestones for expected scholarly contribution, including authorship of publications, grant writing, presentations etc.
The Postdoc Experience Kern, S. (2002). Fellowship Goals for PhDs and MDs: A Primer on the Molecular Biology Postdoctoral Experience. Cancer Biology and Therapy 1: 74-75. National Academy of Sciences. (2000). Enhancing the Postdoctoral Experience for Scientists and Engineers: A Guide for Postdoctoral scholars, Advisers, Institutions, Funding
The Directorate for Social, Behavioral and Economic Sciences (SBE) offers Postdoctoral Research Fellowships to encourage independence early in the fellow's career by supporting his or her research and training goals. The research and training plan of each fellowship must address important scientific questions within the scope of the SBE ...
Objective of Postdoctoral Fellowships. The objective of PFs is to support researchers' careers and foster excellence in research. The Postdoctoral Fellowships action targets researchers holding a PhD who wish to carry out their research activities abroad, acquire new skills and develop their careers. PFs help researchers gain experience in ...
International Postdoctoral Research Fellowships carry a stipend of $50,000. Stipends are payable to fellows only and are disbursed in two equal payments at the beginning and the midpoint of the fellowship term. ... If applicants plan to pursue studies or research outside of the U.S. during the fellowship year, one of the following is required ...
NOTICE - The Fonds de recherche du Québec (FRQ) was established on June 1, 2024, in accordance with the Act to amend the Act respecting the Ministère de l'Économie et de l'Innovation with respect to research. The Fonds de recherche du Québec - Nature et technologies (FRQNT), the Fonds de recherche du Québec - Santé (FRQS) and the Fonds de recherche du Québec - Société et ...
The purpose of this HEAL Initiative program is to: (1) support basic and mechanistic pain research from R15-eligible undergraduate-focused serving institutions, health professional schools or graduate schools; (2) promote integrated, interdisciplinary research partnerships between Principal Investigators (PIs) from R15-eligible institutions and investigators from U.S. domestic institutions ...